Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (237)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KLEINMAN, J. C.
Right arrow Articles by BROCK, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KLEINMAN, J. C.
Right arrow Articles by BROCK, D. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 128, No. 2: 389-401
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health


research-article

MORTALITY AMONG DIABETICS IN A NATIONAL SAMPLE

JOEL C. KLEINMAN1,, RICHARD P. DONAHUE2, MAUREEN I. HARRIS3, FANCHON F. FINUCANE1, JENNIFER H. MADANS1 and DWIGHT B. BROCK4

1Division of Analysis, National Center for Health Statistics Federal Center Building no. 2, Room 2–27, 3700 East-West Highway, Hyattsville, MD 20782
2Clinical and Genetic Epidemiology Branch, Division of Epidemiology and Clinical Applications National Heart, Lung, and Blood Institute, Bethesda, MD
3National Diabetes Data Group, National Institute of Diabetes Digestive and Kidney Diseases, Bethesda, MD
4Biometry Office, Epidemiology, Demography, and Biometry Program, National Institute on Aging Bethesda, MD

Reprint requests to Dr. Joel C. Kleinman

The authors compare the mortality experience of a national sample of diabetic men and women with their nondiabetic counterparts. The study population consists of respondents from the First National Health and Nutrition Examination Survey (NHANES I), conducted in 1971–1975, who were traced in 1982–1984 through the NHANES I Epidemiologic Follow-up Study. Over the nine-year follow-up period, the age-adjusted death rates for diabetic men and women were twice the rates for nondiabetics. About 75% of the excess mortality among diabetic men and 57% among diabetic women was attributable to cardiovascular disease deaths. After adjustment for age, systolic blood pressure, serum cholesterol, body mass index, and smoking, the relative risk of death was 2.3 for diabetic men and 2.0 for diabetic women. The relative risk for diabetics was highest for ischemic heart disease mortality (2.8 for men and 2.5 for women) and lowest for noncardiovascular disease deaths (1.4 for men and 1.1 for women). When subjects who reported having had a heart attack prior to the baseline examination were excluded, the relative risks for ischemic heart disease mortality among diabetics remained substantial (2.4 for men and 2.6 for women). There was little evidence that the relative risk of death for diabetics compared with nondiabetics differed by age or sex, although 95% confidence intervals around these estimates were wide.

cardiovascular diseases; coronary disease; diabetes mellitus; follow-up studies; mortality


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
B. V. Howard, M. J. Roman, R. B. Devereux, J. L. Fleg, J. M. Galloway, J. A. Henderson, Wm. J. Howard, E. T. Lee, M. Mete, B. Poolaw, et al.
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
JAMA, April 9, 2008; 299(14): 1678 - 1689.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
Hypertension, November 1, 2007; 50(5): 984 - 990.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. N. McEwen, C. Kim, A. J. Karter, M. N. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, T. J. Thompson, and W. H. Herman
Risk Factors for Mortality Among Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study
Diabetes Care, July 1, 2007; 30(7): 1736 - 1741.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. M. Okin, R. B. Devereux, E. Gerdts, S. M. Snapinn, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, L. H. Lindholm, et al.
Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
Circulation, March 28, 2006; 113(12): 1588 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. N. McEwen, C. Kim, M. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, M. M. Safford, D. Marrero, T. J. Thompson, W. H. Herman, et al.
Diabetes Reporting as a Cause of Death: Results from the Translating Research Into Action for Diabetes (TRIAD) study
Diabetes Care, February 1, 2006; 29(2): 247 - 253.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
R. Huxley, F. Barzi, and M. Woodward
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
BMJ, January 14, 2006; 332(7533): 73 - 78.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
L. A Leiter, D J. Betteridge, A. R Chacra, A. Chait, E. Ferrannini, S. M Haffner, T. Kadowaki, J. Tuomilehto, P. Zimmet, C. B Newman, et al.
AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus
The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 31 - 40.
[Abstract] [PDF]


Home page
J. Epidemiol. Community HealthHome page
M. Jeffreys, C. Wright, A. 't Mannetje, K. Huang, and N. Pearce
Ethnic differences in cause specific mortality among hospitalised patients with diabetes: a linkage study in New Zealand
J Epidemiol Community Health, November 1, 2005; 59(11): 961 - 966.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. Vijan and R. A. Hayward
Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians
Ann Intern Med, April 20, 2004; 140(8): 650 - 658.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
S. Mudaliar
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents
J. Clin. Pharmacol., April 1, 2004; 44(4): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. M. Okin, R. B. Devereux, E. T. Lee, J. M. Galloway, and B. V. Howard
Electrocardiographic Repolarization Complexity and Abnormality Predict All-Cause and Cardiovascular Mortality in Diabetes: The Strong Heart Study
Diabetes, February 1, 2004; 53(2): 434 - 440.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
S. Vijan and R. A. Hayward
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
Ann Intern Med, April 1, 2003; 138(7): 593 - 602.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. E. Resnick, K. Jones, G. Ruotolo, A. K. Jain, J. Henderson, W. Lu, and B. V. Howard
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians: The Strong Heart Study
Diabetes Care, March 1, 2003; 26(3): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. M. Kanaya, D. Grady, and E. Barrett-Connor
Explaining the Sex Difference in Coronary Heart Disease Mortality Among Patients With Type 2 Diabetes Mellitus: A Meta-analysis
Arch Intern Med, August 12, 2002; 162(15): 1737 - 1745.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
N. Singh
Diabetes, Heart Rate, and Mortality
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 117 - 129.
[Abstract] [PDF]


Home page
CirculationHome page
B. V. Howard, B. L. Rodriguez, P. H. Bennett, M. I. Harris, R. Hamman, L. H. Kuller, T. A. Pearson, and J. Wylie-Rosett
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Circulation, May 7, 2002; 105 (18): e132 - e137.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
DECODE Study Group; on behalf of the European Diab
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
Arch Intern Med, February 12, 2001; 161(3): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. A. Lotufo, J. M. Gaziano, C. U. Chae, U. A. Ajani, G. Moreno-John, J. E. Buring, and J. E. Manson
Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians
Arch Intern Med, January 22, 2001; 161(2): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Palmieri, J. N. Bella, D. K. Arnett, J. E. Liu, A. Oberman, M.-Y. Schuck, D. W. Kitzman, P. N. Hopkins, D. Morgan, D. C. Rao, et al.
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects : Hypertension Genetic Epidemiology Network (HyperGEN) Study
Circulation, January 2, 2001; 103(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. B. Devereux, M. J. Roman, M. Paranicas, M. J. O'Grady, E. T. Lee, T. K. Welty, R. R. Fabsitz, D. Robbins, E. R. Rhoades, and B. V. Howard
Impact of Diabetes on Cardiac Structure and Function : The Strong Heart Study
Circulation, May 16, 2000; 101(19): 2271 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
W. J. Elliott, D. R. Weir, and H. R. Black
Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients
Arch Intern Med, May 8, 2000; 160(9): 1277 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
C. M. Akbari, F. B. Pomposelli Jr, G. W. Gibbons, D. R. Campbell, M. C. Pulling, D. Mydlarz, and F. W. LoGerfo
Lower Extremity Revascularization in Diabetes: Late Observations
Arch Surg, April 1, 2000; 135(4): 452 - 456.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. Klein, B. E. K. Klein, S. E. Moss, and K. J. Cruickshanks
Association of Ocular Disease and Mortality in a Diabetic Population
Arch Ophthalmol, November 1, 1999; 117(11): 1487 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
B. M. Psaty, C. D. Furberg, L. H. Kuller, D. E. Bild, P. M. Rautaharju, J. F. Polak, E. Bovill, and J. S. Gottdiener
Traditional Risk Factors and Subclinical Disease Measures as Predictors of First Myocardial Infarction in Older Adults: The Cardiovascular Health Study
Arch Intern Med, June 28, 1999; 159(12): 1339 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. D. Kanters, J.-D. Banga, R. P Stolk, and A. Algra
Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis
Vascular Medicine, May 1, 1999; 4(2): 67 - 75.
[Abstract] [PDF]


Home page
HeartHome page
J. W SAYER and A. D TIMMIS
Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary?
Heart, December 1, 1997; 78(6): 525 - 526.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
G. E. Fraser and D. J. Shavlik
Risk Factors for All-Cause and Coronary Heart Disease Mortality in the Oldest-Old: The Adventist Health Study
Arch Intern Med, October 27, 1997; 157(19): 2249 - 2258.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. Klein, B. E. K. Klein, and S. E. Moss
Is Obesity Related to Microvascular and Macrovascular Complications in Diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Arch Intern Med, March 24, 1997; 157(6): 650 - 656.
[Abstract] [PDF]


Home page
BMJHome page
N. Chaturvedi, J. Jarrett, N. Morrish, H. Keen, and J. H Fuller
Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study
BMJ, October 5, 1996; 313(7061): 848 - 852.
[Abstract] [Full Text]


Home page
CirculationHome page
P. H. Frost, B. R. Davis, A. J. Burlando, J. David Curb, G. P. Guthrie Jr, J. L. Isaacsohn, S. Wassertheil-Smoller, A. C. Wilson, and J. Stamler
Coronary Heart Disease Risk Factors in Men and Women Aged 60 Years and Older : Findings From the Systolic Hypertension in the Elderly Program
Circulation, July 1, 1996; 94(1): 26 - 34.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
S. Genuth
Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus
Ann Intern Med, January 1, 1996; 124(1_Part_2): 104 - 109.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
S. E. Moss, R. Klein, B. E. K. Klein, and S. M. Meuer
The Association of Glycemia and Cause-Specific Mortality in a Diabetic Population
Arch Intern Med, November 14, 1994; 154(21): 2473 - 2479.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. Garg, D. K. Wagener, and J. H. Madans
Alcohol Consumption and Risk of Ischemic Heart Disease in Women
Arch Intern Med, May 24, 1993; 153(10): 1211 - 1216.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
F. F. Finucane, J. H. Madans, T. L. Bush, P. H. Wolf, and J. C. Kleinman
Decreased Risk of Stroke Among Postmenopausal Hormone Users: Results From a National Cohort
Arch Intern Med, January 11, 1993; 153(1): 73 - 79.
[Abstract] [PDF]


Home page
JAMAHome page
E. L. Barrett-Connor, B. A. Cohn, D. L. Wingard, and S. L. Edelstein
Why Is Diabetes Mellitus a Stronger Risk Factor for Fatal Ischemic Heart Disease in Women Than in Men? The Rancho Bernardo Study
JAMA, February 6, 1991; 265(5): 627 - 631.
[Abstract] [PDF]


Home page
JAMAHome page
D. M. Huse, G. Oster, A. R. Killen, M. J. Lacey, and G. A. Colditz
The Economic Costs of Non--Insulin-Dependent Diabetes Mellitus
JAMA, November 17, 1989; 262(19): 2708 - 2713.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.